[Federal Register Volume 68, Number 33 (Wednesday, February 19, 2003)]
[Notices]
[Page 8032]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-3898]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer 
Liaison Group.
    Date: March 13, 2003.
    Time: 2 p.m. to 5 p.m.
    Agenda: 1. Update on the DCLG Advocacy Survey; 2. Report from 
the Future of the DCLG Working Group; 3. Update on the Consumer 
Advocates in Research and Related (CARRA) program; 4. Tissue Banking 
Project; 5. DCLG Activities Report and Implications; 6. Update on 
the DCLG--Patient Advisory Board (PAB) Clinical Trials Project; 7. 
DCLG Member Reports.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852. (Telephone conference call.)
    Contact Person: Elaine Lee, Executive Secretary, Office of 
Liaison Activities, National Institutes of Health, National Cancer 
Institute, 6116 Executive Boulevard, Suite 300 C, Bethesda, MD 
20892. 301/594-3194.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 10, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-3898 Filed 2-18-03; 8:45 am]
BILLING CODE 4140-01-M